T1DM - TYPE 1 DIABETES MELLITUS
Clinical trials for T1DM - TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new T1DM - TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for T1DM - TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a single CAR-T infusion free some from daily insulin?
Disease control Recruiting nowThis early-phase study tests a one-time infusion of specially engineered immune cells (CAR-T cells) that target and calm the immune attack on the pancreas in people with early type 1 diabetes. The goal is to preserve the body's own insulin-making cells and reduce the need for inj…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new medicine called CNP-103 in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either CNP-103 or a placebo over 90 …
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
Pig cell transplant trial aims to free type 1 diabetes patients from severe lows
Disease control Recruiting nowThis early-phase study tests a new treatment called OPF-310, which uses pig islet cells (the cells that make insulin) placed inside tiny capsules. The goal is to see if transplanting these cells is safe and can help adults with unstable type 1 diabetes who still have dangerous lo…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC